IL41347A - Mineral salt preparation - Google Patents

Mineral salt preparation

Info

Publication number
IL41347A
IL41347A IL41347A IL4134773A IL41347A IL 41347 A IL41347 A IL 41347A IL 41347 A IL41347 A IL 41347A IL 4134773 A IL4134773 A IL 4134773A IL 41347 A IL41347 A IL 41347A
Authority
IL
Israel
Prior art keywords
weight
mineral salt
vitamin
parts
inclusive
Prior art date
Application number
IL41347A
Other versions
IL41347A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL41347A0 publication Critical patent/IL41347A0/en
Publication of IL41347A publication Critical patent/IL41347A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1356096 Mineral salt preparations F HOFFMANN-LA ROCHE & CO AG 23 Feb 1973 [25 Feb 1972] 9053/73 Heading A5B Mineral salt preparations for the replacement of minerals lost by bodily stress and increased transpiration as well as by the use of diuretics, contain in the form of salts, 1 to 16 parts by weight of calcium, 1 to 8 parts by weight of magnesium, 0.4 to 4 parts by weight of potassium and no sodium or less than 0.1 parts by weight of sodium, the calcium, potassium, magnesium and sodium constituting more than 2% by weight of the preparation. The salts may be the appropriate carbonates, phosphates, glycerophosphates, gluconates, ascorbates or D-pantothenates. The preparations may be administered orally in the form of powders, granulates, tablets (e.g. effervescent tablets), drag es, capsules, solutions, suspensions or emulsions. The preparations may also contain phosphates, vitamins, e.g. vitamin C, B 1 , B 2 , B 6 and E, nicotinic acid, nicotinamide, pantothenic acid and/or calcium D-pantothenate; sugars, e.g. glucose, lactose, fructose, saccharose, laevulose, mannitol, sorbitol or xylitol; sweetening agents; aroma additives; acid additives, e.g. citric or tartaric acid, colouring agents; solubilising agents; granulating adjuvants, preservatives; stabilisers; wetting agents; emulsifiers; salts for varying the osmotic pressure and/or buffers. [GB1356096A]

Claims (2)

1. 41347/2
2. ) Process according to claim " 1, wherein a part of the salts, which contain calcium, magnesium, potassium and, if necessary, sodium, is phosphate and wherein the amount of phosphate used is 2 to 2 parts by weight. -3) Process according to claim .1 or claim 2, wherein vitamins and/or adjuvants are added* A) Process according to any one of claims .1 to ~ inclusive, wherein aroma additives are added. -5) Process according to any one of claims .1 to A inclusive, wherein a sweetening agent is added. 41347^2 .6) Process according to any one of claims , 1 to Γ-5 inclusive, wherein- he- mineral, salt preparation is manufactured in the form of a water-soluble granulate,, .7) Process according to any one of claims 1 to .6 inclusive, wherein a sugar is added. .8) Process according to claim 7 » wherein said sugar is fructose, saccharose , laevulose or lactose. . 9) Process according to claim .7 » wherein said sugar is sorbitol , mannitol and/or xylitol. lO), Process according to any one of claims \ to 9 inclusive , wherein salts containing a total, of 250 mg of calcium, 170 mg of magnesium, lOOmg of potassium,' 310 mg of phosphate and other anions are mixed with 500 mg of vitamin C , 10 mg of vitamin 15 m of vitamin B2 , mg of vitamin B^ , 20 mg of nicotinamide , 20 mg o f calcium D--pantothenate , 50 mg of vitamin E and adjuvants to 10, 000 mg. 11) Mineral salt preparation for the replacement of minerals lost by bodily stress and increased transpiration as well as by the use of diuretics, said preparation containing, in the form of salts, 1 to 16 parts by weight of calcium, 1 to 8 parts by weight of magnesium, 0.4- to parts by weight of potassium and no sodium or less than · 0.1 parts by weight of sodium; the weight ratio of calcium, 41^47/2 potassium, magnesium and sodium to the total weight of the preparation lying above 2%. 2 j) Mineral salt preparation according to contains 2 to 2 parts by weight of phosphate. 13) Mineral salt preparation according to clairn H or claim 22 which contains vitamins and/or adjuvants. 4 ) Mineral salt preparation according to any one of claims 11 to 15 inclusive which contains an aroma additive. 15 ) Mineral salt preparation according to any one of claims n to 14 inclusive whioh contains a sweetening agent 16 ) Mineral salt preparation according to any one of claims 11 to 15! inclusive which is present in the form of a water-soluble granulate. 17 ) Mineral salt preparation according to any one of claims 11 to 16 inclusive which contains a sugar. 18) Mineral salt preparation according to claim 17 , wherein said sugar is fructose, saccharose, laevulose or lactose. 19) Mineral salt preparation according to claim- l'7 t wherein said sugar is sorbitol, mannitol and/or xylitol. 20) Mineral salt preparation according to any one of claims H to 16 inclusive of the following compositions Vitamin C 500 mg Vitamin B1 10 mg Vitamin B2 15 mg Vitamin Bg 25 mg Nicotinamide 20 mg Clacium D-pantothenate 20 mg Vitamin E 50 mg Calcium 250 mg Magnesium 170 mg Potassium 100 mg Phosphate 310 mg together with other anions and adjuvants to 10, 000 mg. For the Applicants
IL41347A 1972-02-25 1973-01-19 Mineral salt preparation IL41347A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH271972 1972-02-25

Publications (2)

Publication Number Publication Date
IL41347A0 IL41347A0 (en) 1973-03-30
IL41347A true IL41347A (en) 1976-04-30

Family

ID=4240056

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41347A IL41347A (en) 1972-02-25 1973-01-19 Mineral salt preparation

Country Status (14)

Country Link
JP (1) JPS4896712A (en)
AT (1) AT322743B (en)
AU (1) AU462328B2 (en)
BE (1) BE795827A (en)
CA (1) CA1023991A (en)
DE (1) DE2305979A1 (en)
FR (1) FR2173262B1 (en)
GB (1) GB1356096A (en)
IE (1) IE37291B1 (en)
IL (1) IL41347A (en)
NL (1) NL7301864A (en)
PH (1) PH9888A (en)
SE (1) SE422273B (en)
ZA (1) ZA73288B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI60107C (en) * 1978-02-24 1982-12-13 Suomen Laeaeketehdas Oy Salco SOM KRYDDA ELLER SOM KONSERVERINGSMEDEL FOER LIVSMEDEL ANVAENDBAR BORDSSALTPRODUKT
JPS579712A (en) * 1980-06-20 1982-01-19 Fukumi Morishige Instilling (dripping) liquid for intravenous injection
FI834309A (en) * 1983-11-24 1985-05-25 Pharmaconsult Oy SALTBLANDNING.
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US9974319B2 (en) 2006-03-29 2018-05-22 Purac Biochem B.V. Partially neutralized polycarboxylic acids for acid-sanding

Also Published As

Publication number Publication date
SE422273B (en) 1982-03-01
ZA73288B (en) 1973-10-31
AU5122773A (en) 1974-07-18
AT322743B (en) 1975-06-10
BE795827A (en) 1973-08-23
FR2173262A1 (en) 1973-10-05
CA1023991A (en) 1978-01-10
IL41347A0 (en) 1973-03-30
FR2173262B1 (en) 1975-10-10
IE37291B1 (en) 1977-06-22
PH9888A (en) 1976-06-08
GB1356096A (en) 1974-06-12
JPS4896712A (en) 1973-12-10
DE2305979A1 (en) 1973-08-30
NL7301864A (en) 1973-08-28
IE37291L (en) 1973-08-25
AU462328B2 (en) 1975-06-19

Similar Documents

Publication Publication Date Title
Karlish et al. On the Mechanism of Uncoupling in Chloroplasts by Ion‐Permeability Inducing Agents
GB1405088A (en) Slow release formulation
US2822317A (en) Aqueous iron-ascorbic acid preparation
GB1503886A (en) Nonalcoholic beverages
IL41347A (en) Mineral salt preparation
JP2000189125A (en) Acidic drinking liquid composition
GR3004440T3 (en)
IE37292L (en) Mineral salt preparation
GB1256968A (en)
GB1344558A (en) Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
GB2308810A (en) Composition for combatting dehydration
IE801914L (en) Paracetamol compositions
US3777029A (en) Chewable multivitamin tablets contain-ing aluminum nicotinate
GB1191246A (en) Vitamin-containing Preparations
GB1165098A (en) Improvements in the Preparation of Chlorine-Producing Bactericidal Compositions
ES264510A1 (en) Improvements in or relating to pharmaceutical iron preparations
IE44704L (en) ß-LACTAM ANTIBIOTIC
GB1268292A (en) 2-furfurylthioinosine and derivatives thereof
US2480517A (en) Fused riboflavin-amide
GB1234328A (en)
GB883169A (en) Dry effervescent concentrate
GB1273092A (en) 2-allyloxyinosine-5'-phosphate
IE38113L (en) Anti-smoking preparations
IE38383L (en) Doxycycline parenteral composition
JPH02240025A (en) Stable aqueous solution of complex vitamin